Intellia Therapeutics Inc (FRA:38I)
€ 13.565 -0.175 (-1.27%) Market Cap: 1.44 Bil Enterprise Value: 903.64 Mil PE Ratio: 0 PB Ratio: 1.53 GF Score: 57/100

Q2 2019 Intellia Therapeutics Inc Earnings Call Transcript

Aug 01, 2019 / 12:00PM GMT
Release Date Price: €16.4 (-0.12%)
Operator

My name is John, and I will be your conference operator today. Welcome to the Intellia Therapeutics Second Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

At this time, I would like to turn the call over to Lina Li, Associate Director of Intellia. Please proceed.

Lina Li
Intellia Therapeutics, Inc. - Senior Manager of IR

Thank you, operator. Good morning and thank you all for joining us today to discuss Intellia's second quarter 2019 operational highlights and financial results. Earlier this morning, we issued a press release outlining our progress this quarter and the topics we plan to discuss on today's call. This release can be found on the Investors section of our website at www.intelliatx.com. This call is being broadcasted live and a replay will also be archived on our website.

Before we get started, I would like to remind you that during this call, we may make certain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot